Back to VRCA
RENAISSANCE TECHNOLOGIES LLC → VRCA
RENAISSANCE TECHNOLOGIES LLC VRCA Position History
Verrica Pharmaceuticals Inc. • Healthcare
Quarters held
15
Latest value
$153K
Q3 2026
Peak value
$919K
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $92K |
| Q3 2022 | $672K |
| Q4 2022 | $430K |
| Q1 2023 | $367K |
| Q2 2023 | $919K |
| Q3 2023 | $265K |
| Q2 2024 | $332K |
| Q3 2024 | $215K |
| Q4 2024 | $163K |
| Q2 2025 | $46K |
| Q3 2025 | $126K |
| Q4 2025 | $219K |
| Q1 2026 | $171K |
| Q2 2026 | $133K |
| Q3 2026 | $153K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153K | 31.9K | — | — |
| Q2 2026 | $133K | 21.8K | — | — |
| Q1 2026 | $171K | 32.4K | — | — |
| Q4 2025 | $219K | 26.4K | — | — |
| Q3 2025 | $126K | 29.2K | — | — |
| Q2 2025 | $46K | 87.2K | — | — |
| Q4 2024 | $163K | 233.3K | — | — |
| Q3 2024 | $215K | 148.0K | — | — |
| Q2 2024 | $332K | 45.5K | — | — |
| Q3 2023 | $265K | 68.1K | — | — |
| Q2 2023 | $919K | 159.3K | — | — |
| Q1 2023 | $367K | 56.5K | — | — |
| Q4 2022 | $430K | 156.4K | — | — |
| Q3 2022 | $672K | 230.3K | — | — |
| Q2 2022 | $92K | 47.9K | — | — |
Other funds holding VRCA
$11M
$8.9M
$8.8M
$8.1M
$7.7M
$6.7M